{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T07:55:14Z","timestamp":1789977314706,"version":"4.0.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"38","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.vaccine.2016.07.038","type":"journal-article","created":{"date-parts":[[2016,7,28]],"date-time":"2016-07-28T16:10:15Z","timestamp":1469722215000},"page":"4543-4550","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Impact of PCV7\/PCV13 introduction on invasive pneumococcal disease (IPD) in young children: Comparison between meningitis and non-meningitis IPD"],"prefix":"10.1016","volume":"34","author":[{"given":"S.","family":"Ben-Shimol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Givon-Lavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Schlesinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Miron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Aviner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Dagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9693","key":"10.1016\/j.vaccine.2016.07.038_b0005","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","article-title":"Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates","volume":"374","author":"O\u2019Brien","year":"2009","journal-title":"Lancet"},{"issue":"46","key":"10.1016\/j.vaccine.2016.07.038_b0010","doi-asserted-by":"crossref","first-page":"6600","DOI":"10.1016\/j.vaccine.2012.08.012","article-title":"Rapid reduction in invasive pneumococcal disease after introduction of PCV7 into the National Immunization Plan in Israel","volume":"30","author":"Ben-Shimol","year":"2012","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2016.07.038_b0015","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s12325-013-0051-2","article-title":"A review of the impact of pneumococcal polysaccharide conjugate vaccine (7-valent) on pneumococcal meningitis","volume":"30","author":"Tin Tin Htar","year":"2013","journal-title":"Adv Ther"},{"issue":"9546","key":"10.1016\/j.vaccine.2016.07.038_b0020","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0140-6736(06)69637-2","article-title":"Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study","volume":"368","author":"Whitney","year":"2006","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.vaccine.2016.07.038_b0025","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3201\/eid1605.091223","article-title":"Effects of pneumococcal conjugate vaccine 2 years after its introduction, the Netherlands","volume":"16","author":"Rodenburg","year":"2010","journal-title":"Emerg Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2016.07.038_b0030","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1097\/INF.0b013e318232ee3e","article-title":"Evolution of the epidemiology of pneumococcal disease among Utah children through the vaccine era","volume":"30","author":"Ampofo","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.vaccine.2016.07.038_b0035","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1086\/648593","article-title":"Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine","volume":"201","author":"Pilishvili","year":"2010","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2016.07.038_b0040","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1086\/374624","article-title":"Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential","volume":"187","author":"Brueggemann","year":"2003","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2016.07.038_b0045","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1086\/381686","article-title":"Effect of clonal and serotype-specific properties on the invasive capacity of Streptococcus pneumoniae","volume":"189","author":"Sandgren","year":"2004","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2016.07.038_b0050","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/cid\/civ368","article-title":"Impact of the 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis in US children","volume":"61","author":"Olarte","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2016.07.038_b0055","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.vaccine.2015.12.010","article-title":"Early Streptococcus pneumoniae serotype changes in Utah adults after the introduction of PCV13 in children","volume":"34","author":"Kendall","year":"2016","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2016.07.038_b0060","doi-asserted-by":"crossref","first-page":"21057","DOI":"10.2807\/1560-7917.ES2015.20.10.21057","article-title":"Impact of 10- and 13-valent pneumococcal conjugate vaccines on incidence of invasive pneumococcal disease in children aged under 16 years in Germany, 2009 to 2012","volume":"20","author":"Weiss","year":"2015","journal-title":"Euro Surveill"},{"issue":"3","key":"10.1016\/j.vaccine.2016.07.038_b0065","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1017\/S095026881500179X","article-title":"Impact of the 13-valent pneumococcal conjugate vaccine on the incidence of pneumococcal meningitis in children","volume":"144","author":"Chapoutot","year":"2016","journal-title":"Epidemiol Infect"},{"issue":"12","key":"10.1016\/j.vaccine.2016.07.038_b0070","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1097\/INF.0000000000000451","article-title":"Trends of pneumococcal meningitis in children after introduction of the 13-valent pneumococcal conjugate vaccine in France","volume":"33","author":"Levy","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2016.07.038_b0075","unstructured":"Central bureau of statistics. Statistical abstract of Israel No. 65 2014. Jerusalem: State of Israel; 2014."},{"issue":"2","key":"10.1016\/j.vaccine.2016.07.038_b0080","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1080\/21645515.2015.1095414","article-title":"Pneumococcal nasopharyngeal carriage in children <5 years of age visiting the pediatric emergency room in relation to PCV7 and PCV13 introduction in southern Israel","volume":"12","author":"Ben-Shimol","year":"2016","journal-title":"Hum Vaccin Immunother"},{"issue":"36","key":"10.1016\/j.vaccine.2016.07.038_b0085","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1016\/j.vaccine.2015.06.062","article-title":"Impact of PCV7\/PCV13 introduction on community-acquired alveolar pneumonia in children <5 years","volume":"33","author":"Greenberg","year":"2015","journal-title":"Vaccine"},{"issue":"27","key":"10.1016\/j.vaccine.2016.07.038_b0090","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1016\/j.vaccine.2014.03.065","article-title":"Early impact of sequential introduction of 7-valent and 13-valent pneumococcal conjugate vaccine on IPD in Israeli children <5 years: an active prospective nationwide surveillance","volume":"32","author":"Ben-Shimol","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.07.038_b0095","doi-asserted-by":"crossref","unstructured":"Rokney A, Ben-Shimol S, Korenman Z, Porat N, Gorodnitzky Z, Yashar R, et al. The dynamics of invasive pneumococcal disease caused by serotype 12F following the sequential introduction of PCV7\/PCV13 in Israel [049]. In: Presented at the 10th international symposium on pneumococci and pneumococcal diseases (ISPPD). Glasgow, Scotland, June 26th\u201330th; 2016.","DOI":"10.26226\/morressier.5731f0d2d462b8029238002d"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16306223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16306223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T09:34:22Z","timestamp":1600940062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16306223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":19,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S0264410X16306223"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.07.038","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of PCV7\/PCV13 introduction on invasive pneumococcal disease (IPD) in young children: Comparison between meningitis and non-meningitis IPD","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.07.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}